SHARON HALE: Open Payments
NPI 1346470929 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 30 payments from 16 companies in 2025. Trend: 2023 $173 · 2024 $410 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| PFIZER INC. | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| ABBVIE INC. | 2 | $44 |
| TerSera Therapeutics LLC | 2 | $40 |
| AVYXA PHARMA, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| SpringWorks Therapeutics, Inc. | 1 | $23 |
Products named: Enhertu, LIBTAYO, KEYTRUDA, IBRANCE, IMFINZI, FRINDOVYX, JEMPERLI, EMRELIS.
Industry payments across TN — which companies pay providers there.
